Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 12, 2003, Pages 1000-1005

  Androudi, Sofia ^a   Brazitikos, Periklis ^b   Iaccheri, Barbara ^a   Fiore, Tito ^a   Christen, William ^c   Meniconi, Margherita ^a   Foster, C Stephen ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DRUG DERIVATIVE; FOLIC ACID; HLA B27 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ARTICLE; CATARACT; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG COMBINATION; DRUG EFFICACY; EYE INFLAMMATION; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SLIT LAMP; TIME; TONOMETRY; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; UVEITIS; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ADULT; AZATHIOPRINE; CHRONIC DISEASE; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HLA-B27 ANTIGEN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS;

EID: 0348230348     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0789-3     Document Type: Article

References (26)

1. Belmont JB, Michelson JB (1982) Vitrectomy in uveitis associated with ankylosing spondylitis. Am J Ophthalmol 94:300-304
2. Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Banares A (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14:340-343
3. Brewerton DA, Caffrey M, Nicholls A, Waiters D, James DC (1973) Acute anterior uveitis and HLA-B27. Lancet 2:994-996
4. Derhaag PJ, van der Horst AR, de Waal LP, Feltkamp TE (1989) HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex. Invest Ophthalmol Vis Sci 30:2160-164
5. Dodds EM Lowder CY, Meisler DM (1999) Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm 7:85-92
6. Foster CS (2002) General principles and philosophy. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. Saunders, Philadelphia, pp 27-33
7. Foster CS, Vitale AT (2002) Immuno-suppressive chemotherapy. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. Saunders, Philadelphia, pp 177-209
8. Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM (2003) Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 121:437-440
9. Linssen A, Meenken C (1995) Outcomes of HLA-B27 positive and HLA-B27 negative acute anterior uveitis. Am J Ophthalmol 120:351-361
10. Martin TM, Doyle TM, Smith JR, Reveille JD, Bruckel J, Wade NK, Levinson RD, Rosenbaum JT (2001) Acute anterior uveitis in families. Invest Ophthalmol Vis Sci 42:S708
11. Miserocchi E, Baltatzis S, Ekong A, Roque M, Foster CS (2002) Efficacy and safety of chlorambucil in intractable noninfectious uveitis. Ophthalmology 109:137-142
12. Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106:2301-2306
13. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS (1998) Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105:1646-1651
14. Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res 15:1006-1013
15. Resnick HE, Harris MI, Brock DB, Harris TB (2000) American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 23:176-180
16. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS (1994) Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 101:1267-1274
17. Rodriguez A, Calonge M, Pedrosa-Seres M, Akova YA, Messmer EM, D'Amico DJ, Foster CS (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114:593-599
18. Rothova A, van Veenendaal WG, Linssen A, Glasius E, Kijlstra A, De Jong PT (1987) Clinical features of acute anterior uveitis. Am J Ophthalmol 103:137-145
19. Samson MC, Waheed N, Baltatzis S, Foster CS (2002) Methotrexate therapy for chronic noninfectious uveitis. Ophthalmology 108:1134-1139
20. Shabrawi YE, Hermann J (2002) Antitumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 109:2342-2346
21. Shawkat SM, Foster CS (2002) Definition, classification, etiology and epidemiology. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. Saunders, Philadelphia, pp 17-26
22. Smith RJ (2002) HLA-B27- associated uveitis. Ophthalmol Clin North Am 15:297-307
23. Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA (1996) Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 121:47-56
24. Wakefield D, Montanaro A, McCluskey P (1991) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 36:223-232
25. Wakefield D, McCluskey P, Verma M, Aziz K, Gatus B, Carr G (1999) Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 42:1894-1897
26. Williamson J, Paterson RW, McGavin DM, Jasani MK, Boyle JA, Doig WM (1969) Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy. Br J Ophthalmol 53:361-372